According to a new report LAMEA mHealth Market, published by KBV research, the LAMEA mHealth Market would witness market growth of 32.4% CAGR during the forecast period (2020-2026).
The Brazil market dominated the LAMEA Diagnosis services Market by Country in 2019, and would continue to be a dominant market till 2026. The Argentina market would witness a CAGR of 31.9% during (2020 - 2026). Additionally, The UAE market is poised to grow at a CAGR of 30.1% during (2020 - 2026).
The Mobile Operators market dominated the Saudi Arabia mHealth Market by Stakeholders in 2019, growing at a CAGR of 31.9 % during the forecast period. The Device Vendors market is projected to grow at a CAGR of 32.1% during (2020 - 2026). The Healthcare Providers market is exhibiting a CAGR of 34.4% during (2020 - 2026). Additionally, The Content Players market would showcase highest CAGR of 35.4% during (2020 - 2026).
The BP Monitors market dominated the South Africa mHealth Market by Devices in 2019, and would thereby, achieving a market value of $297.8 million by 2026. The Cardiac Monitors market is would showcase a CAGR of 33.4% during (2020 - 2026). The Pulse Oximetry market is witnessing a CAGR of 34% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/lamea-mhealth-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer AG, Medtronic PLC, Johnson and Johnson, Koninklijke Philips N.V., DexCom, Inc., Samsung Electronics Co., Ltd. (Samsung Group), Omron Corporation, AllScripts Healthcare Solutions, Inc., Sanofi S.A., Cerner Corporation.
By Type
By Services
By Devices
By Stakeholders
Content Players
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
